Dendritic Cell (DC1) Vaccine
MCC-21378
Phase 1 mab active
Quick answer
Dendritic Cell (DC1) Vaccine for HER2-positive Breast Cancer is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- HER2-positive Breast Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active